This revealed that IGF2BP1 also serves SRF-independent roles in cancer cells and thus supports the notion that IGF2BP1 promotes an ‘aggressive’ tumor cell phenotype via pleiotropic effectors (6). The gene discussed is IGF2BP1; the disease is cancer.